Customer Center
Login | Register


VERIGENE® Gastrointestinal Infection Tests

Diarrhea caused by gastrointestinal pathogens represents a significant clinical concern for providers and patients, and a workflow burden for the laboratory



Bacteria, Viruses, and Parasites from Food, Water, and Environment


Community-acquired diarrhea is typically caused by consumption of contaminated food or water containing bacterial, viral, or parasitic gastrointestinal pathogens.


  • 1.4 episodes of community-acquired diarrhea occur per person every year in the United States.2
  • Most cases are self-resolving and not life-threatening, yet some can have serious implications.


Since symptoms alone are not sufficient to make treatment decisions, rapid identification of the bacterial or viral cause of diarrhea is critical for optimal patient management, and to ensure no inappropriate or unnecessary treatment is provided.



C. difficile


Healthcare-associated diarrhea, caused by Clostridium difficile, primarily affects patients within the healthcare system who are currently on antibiotics and can have significant implications, including higher associated mortality and healthcare costs.


  • C. difficile infections (CDI) are responsible for 250,000 hospitalizations and at least 14,000 deaths in the United States.1
  • 90% of CDI-related deaths occur in those over the age of 65.1
  • Hospitalized patients who are exposed to antibiotics are more susceptible to the disease.
  • Recurrence rates of 15-35% lead to at least $1 billion in excess medical costs per year.1

The VERIGENE Difference


Conventional diagnostics include culture, ova and parasite exams, and antigen detection tests. These methods, however, are labor-intensive, unpleasant for technologists to perform, have low sensitivity, and can take as long as five to seven days to produce definitive results.


The VERIGENE® C. difficile Test (CDF) for healthcare-acquired diarrhea with 027 hypervirulent strain differentiation and VERIGENE® Enteric Pathogens Test (EP) for community-acquired diarrhea with nine bacterial and viral targets require less than five minutes of user hands-on time and deliver comprehensive results directly from a stool sample in less than two hours. As a result, the VERIGENE System provides earlier optimization for patient treatment and improved laboratory and hospital efficiency.


The VERIGENE® Clostridium Difficile Test (CDF) is an automated, multiplex test for rapid identification of C. difficile bacteria, including the PCR ribotype 027 hypervirulent strain.
Read More


The VERIGENE® Enteric Pathogens Test (EP) is an automated, multiplexed molecular diagnostic for the simultaneous detection and identification of common pathogenic enteric bacteria, viruses and genetic virulence markers.
Read More


  1. Centers for Disease Control and Prevention, U.S. Department of Health and Human Services. Antibiotic Resistance Threats in the United States, 2013. Accessed December 31, 2013.
  2. Herikstad H, Yang S, Van Gilder TJ, et al. A population-based estimate of the burden of diarrhoeal illness in the United States: FoodNet, 1996-7. Epidemiol Infect 2002; 129:9-17.


For In Vitro Diagnostic Use. Products are region specific and may not be approved in some countries/regions. Please contact Luminex at [email protected] to obtain the appropriate product information for your country of residence.